Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total 0 out of 5 stars
ease 0 out of 5 stars
features 0 out of 5 stars
design 0 out of 5 stars
support 0 out of 5 stars

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • FrameworkLTC Reviews & Ratings
    4.4 out of 5 stars 48 Ratings
    Company Website for FrameworkLTC
  • CredentialStream Reviews & Ratings
    4.0 out of 5 stars 190 Ratings
    Company Website for CredentialStream
  • AthenaHQ Reviews & Ratings
    4.9 out of 5 stars 50 Ratings
    Company Website for AthenaHQ
  • D&B Risk Analytics Reviews & Ratings
    4.4 out of 5 stars 81 Ratings
    Company Website for D&B Risk Analytics
  • DialedIn Reviews & Ratings
    4.8 out of 5 stars 625 Ratings
    Company Website for DialedIn
  • 3D Cloud Reviews & Ratings
    4.7 out of 5 stars 42 Ratings
    Company Website for 3D Cloud
  • MikMak Reviews & Ratings
    4.5 out of 5 stars 85 Ratings
    Company Website for MikMak
  • Qloo Reviews & Ratings
    5.0 out of 5 stars 23 Ratings
    Company Website for Qloo
  • Fraud.net Reviews & Ratings
    4.6 out of 5 stars 56 Ratings
    Company Website for Fraud.net
  • Evertune Reviews & Ratings
    5.0 out of 5 stars 1 Rating
    Company Website for Evertune

What is DrugPatentWatch?

In the global biopharmaceutical industry, business intelligence centers around understanding the evolving dynamics of drug patents and the emergence of generic medications. Accurately predicting future financial requirements and actively identifying generic substitutes are crucial for sustained success. By examining the successes of former patent challengers, companies can gain valuable insights into the competitive environment and shape their research trajectories. This kind of analysis is essential for informing portfolio management strategies for upcoming drug development initiatives. Moreover, effectively anticipating when patents for branded medications will expire, identifying likely generic suppliers, and managing the inventory of branded drugs are critical tasks. In addition, obtaining comprehensive data on formulation and manufacturing enables the identification of pivotal formulators, repackagers, and relabelers, which can optimize operations and improve market positioning. Grasping these factors is vital, as it can lead to enhanced strategic decision-making, ultimately driving the biopharmaceutical sector toward innovation and growth. By leveraging this intelligence, companies can better navigate the complexities of the market to stay ahead of the competition.

What is Atomwise?

Our cutting-edge AI platform is transforming the drug discovery landscape, allowing us to create high-quality medications more rapidly than ever before. Backed by a wide array of discovery assets, both independently owned and co-developed with partners, and supported by prestigious investors, we are making considerable advancements in the sector. Atomwise has developed a machine-learning discovery engine that harnesses the power of convolutional neural networks in conjunction with vast chemical libraries to pinpoint new small-molecule drugs. The true potential of AI in revolutionizing drug discovery is rooted in the dedication and expertise of our team. We are committed to developing state-of-the-art AI tools that enhance the discovery of small molecules, targeting some of the most challenging and seemingly impossible objectives while optimizing the overall drug development process. By increasing computational efficiency, we can digitally screen trillions of compounds, significantly improving the likelihood of successful outcomes. Our models have achieved exceptional accuracy, effectively reducing the occurrence of false positives and setting the stage for groundbreaking medical innovations. As we continue to refine our technology, our ultimate goal is to equip researchers with the necessary tools to inspire innovation and deliver impactful results in the realm of drug discovery. This commitment to advancing the field is at the core of our mission.

Media

Media

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

API Availability

API Availability

Pricing Information

$250 per month
Free Version

Pricing Information

Pricing not provided

Supported Platforms

SaaS

Supported Platforms

SaaS

Customer Service / Support

Web-Based Support

Customer Service / Support

Web-Based Support

Training Options

Not specified

Training Options

Documentation Hub
Webinars
On-Site Training

Company Facts

Organization Name

DrugPatentWatch

Date Founded

2003

Company Location

United States

Company Website

www.drugpatentwatch.com

Company Facts

Organization Name

Atomwise

Date Founded

2012

Company Location

United States

Company Website

www.atomwise.com

Categories and Features

Drug Discovery

Not specified

Categories and Features

Drug Discovery

Not specified

Healthcare AI

Not specified

Popular Alternatives

Popular Alternatives

StarDrop Reviews & Ratings

StarDrop

Optibrium
Healnet Reviews & Ratings

Healnet

Healx
AIDDISON Reviews & Ratings

AIDDISON

Merck KGaA
BIOiSIM Reviews & Ratings

BIOiSIM

VERISIMLife